Nocopi Technologies Inc. in brief
Nocopi Technologies Inc. is a listed company in the Chemicals industry, based in King Of Prussia, Pennsylvania, USA. Its last known market value was $28 M (July 2023); there is no current figure. In the year to December 2025 it had sales of $1 M and a net loss of $0 M. Its largest product and service lines by sales in 2025 were Productand Other Sales (59%) and Licenses Royalties And Fees (41%). By market, the largest shares of its 2025 sales came from Asia (55%), North America (40%) and Australia (5%).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Nocopi Technologies Inc.
Nocopi Technologies, Inc. develops and markets specialty reactive inks for multiple applications across various industries. Our specialty inks are used by our customers for a range of purposes from bringing entertainment products to life with a variety of color activations to providing document and brand authentication for security purposes aimed at reducing losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. Our primary markets are the large educational and toy products industry and the document and product authentication industry. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to our licensees or to their licensed printers.
From the company's annual report filed with the US SEC: read the report
Nocopi Technologies Inc. timeline
- 1996
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2022
- 💰Record revenue of $5 millionFY2022, the highest of the 8 years on record.
- 💰Record net income of $2 millionFY2022, the highest profit of the 5 years on record.
Events of Nocopi Technologies Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #5,641 (Jan 2022) · #5,174 (Dec 2022) · #5,045 (Jul 2023)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- -10.1%
- Operating margin
- -40.3%
- Return on equity
- -1.1%
- Liabilities / assets
- 3.1%
- Revenue growth
- -29.7%
- R&D / revenue
- 12.1%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1M | -29.7% | $-1M | $-0M | -10.1% |
| Dec 2024 | $2M | +1.9% | $-3M | $-3M | -126.4% |
| Dec 2023 | $2M | -55.1% | $-2M | $-1M | -69.2% |
| Dec 2022 | $5M | +137.4% | $2M | $2M | 39.1% |
| Dec 2021 | $2M | -26.7% | $0M | $0M | 2.6% |
| Dec 2020 | $3M | +4.7% | $0M | $1M | 19.2% |
| Dec 2019 | $3M | -24.0% | $1M | $1M | 29.5% |
| Dec 2018 | $3M | — | $2M | $2M | 49.7% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $1M | $0M | $1M | $-0.01 | — |
| Dec 2024 | $1M | $0M | $1M | $-0.25 | — |
| Dec 2023 | $-0M | $0M | $-0M | $-0.15 | — |
| Dec 2022 | $-0M | $0M | $-0M | $0.24 | — |
| Dec 2021 | $1M | $0M | $0M | $0.01 | — |
| Dec 2020 | $1M | $0M | $1M | $0.01 | — |
| Dec 2019 | $0M | $0M | $0M | $0.01 | — |
| Dec 2018 | $0M | $0M | $0M | $0.03 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $3M (+753.8% on a year earlier), net income $1M. Lighter bars: fourth quarters worked out from the annual report.
SEC filings
- Nov 12, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Oct 16, 2026S-1IPO registration
- Oct 2, 20268-KCurrent reportDirectors or officers changed
- Aug 13, 202610-QQuarterly report · period to Jun 2026
- Jul 31, 20268-K/ACurrent report (amended)
- Jun 23, 20268-KCurrent reportShareholder vote
- May 21, 20268-KCurrent reportMaterial agreement · Acquisition or disposal completed · Unregistered share sale · Regulation FD disclosure
- May 15, 202610-QQuarterly report · period to Mar 2026
- Apr 30, 2026DEF 14AProxy statement
- Mar 31, 202610-KAnnual report · period to Dec 2025
- Jan 5, 20268-KCurrent reportMaterial agreement · Unregistered share sale
Official filings of Nocopi Technologies Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $1 M
- Operating income
- $-1 M
- Net income
- $-0 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $14 M
- Total liabilities
- $0 M
- Total equity
- $14 M
As of December-2025
Insider trading at Nocopi Technologies Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Phillip Frost10% owner | Grant or awardindirect | +21,930 | — | — | 1.51 M | Form 4 |
| filed | Eric SitesDirector | Buy | +500 | $1.800 | $900 | 2,500 | Form 4 |
| filed | Eric SitesDirector | Buy | +1,000 | $1.850 | $2 K | 2,000 | Form 4 |
| filed | Eric SitesDirector | Buy | +1,000 | $1.900 | $2 K | 1,000 | Form 4 |
| filed | Matthew C. WingerChief Executive Officer, Director | Buy | +200 | $1.800 | $360 | 251,116 | Form 4 |
| filed | Matthew C. WingerChief Executive Officer, Director | Buy | +5,000 | $1.710 | $9 K | 250,916 | Form 4 |
| filed | Matthew C. WingerChief Executive Officer, Director | Grant or award | +10,000 | — | — | 245,916 | Form 4 |
| filed | Debra Elyse GlickmanChief Financial Officer | Grant or award | +10,000 | — | — | 17,640 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Nocopi Technologies Inc. scorecard#
Passes 1 of the 15 checks that could be worked out: strongest in financial health (1 of 3), weakest in growth (0 of 6). Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth0 of 6
- ✗Revenue grew in the newest year-29.7%Revenue down 29.7% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years-31.5%-31.5% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median-31.5%-31.5% a year against Chemicals's median of -2.9% (60 companies).
- ✗Earnings per share grew in the newest year-0.01 vs -0.25Diluted EPS -0.01 in fiscal 2025 against -0.25 the year before (report's currency).
- ✗Net income higher than five years earlier-$0 M-$0 M in fiscal 2025 against $1 M in 2020.
- ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2025.
Profitability0 of 5
- ✗Profitable in the newest year-$0 MNet income -$0 M in fiscal 2025.
- ✗Profitable in each of the last five years2 of 5Profitable in 2 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-40.3%-40.3% against Chemicals's median of 4.4% (73 companies).
- ✗Return on equity above 15%-1.1%-1.1% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-40.3%-40.3% in fiscal 2025 against 44.3% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities45.1×Current ratio 45.14 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-30.0×Operating income -30.0 times interest in fiscal 2025.
- ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2025.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year2.5%Diluted shares up 2.5% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Chemicals, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Nocopi Technologies Inc.'s statements, beside the median of Chemicals.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -40.3% | 4.4% | |
| Net margin | -10.1% | 2.1% | |
| Return on equity | -1.1% | 1.9% | |
| Revenue growth, 3 years a year | -31.5% | -2.9% | |
| Revenue growth | -29.7% | -0.8% | |
| Free cash flow margin | 47.7% | 3.6% |
4of 8on the Piotroski tests of financial strength
- Revenue fell 29.7% against the year before.
- Net loss of $0 million, the 3th loss-making year in a row.
- Operating income covers the interest bill only -30.0 times.
Nocopi Technologies Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 1,494−29.5%100% | 2,118+1.6%100% | 2,084−55.0%100% | 4,627+137%100% | 1,952−26.6%100% | 2,659+4.8%100% | 2,537−24.1%100% | 3,342+113%100% | 1,567+13.3%100% | 1,384—100% | |
| Cost of revenue | 680−33.1%45.5% | 1,018+3.6%48.0% | 982+34.9%47.1% | 728−1.4%15.7% | 738−34.3%37.8% | 1,124+33.5%42.3% | 842+50.0%33.2% | 561+26.7%16.8% | 443+0.2%28.3% | 442—32.0% | |
| Gross profit | 813−26.1%54.5% | 1,100−0.1%52.0% | 1,102−71.7%52.9% | 3,900+221%84.3% | 1,214−20.9%62.2% | 1,535−9.5%57.7% | 1,696−39.0%66.8% | 2,781+147%83.2% | 1,124+19.4%71.7% | 941—68.0% | |
| Research and development | 180+1.0%12.0% | 178+9.1%8.4% | 163+16.4%7.8% | 140−22.6%3.0% | 182+4.6%9.3% | 174+4.8%6.5% | 166+8.1%6.5% | 153+4.7%4.6% | 146+5.4%9.3% | 139—10.0% | |
| Selling and marketing | 283−12.3%18.9% | 322+19.1%15.2% | 271−45.2%13.0% | 495+71.9%10.7% | 288−19.3%14.7% | 356+8.0%13.4% | 330−14.8%13.0% | 387+52.7%11.6% | 254+7.5%16.2% | 236—17.1% | |
| General and administrative | 952−75.6%63.8% | 3,900+53.6%184% | 2,538+108%122% | 1,219+69.5%26.3% | 719+36.7%36.9% | 526+33.6%19.8% | 394+6.6%15.5% | 369+16.3%11.1% | 318+7.7%20.3% | 295—21.3% | |
| Operating expenses | 1,415−67.8%94.7% | 4,401+48.0%208% | 2,973+60.3%143% | 1,854+56.0%40.1% | 1,189+12.6%60.9% | 1,056+18.7%39.7% | 889−2.3%35.1% | 910+26.8%27.2% | 718+7.2%45.8% | 670—48.4% | |
| Operating income | −601—−40.3% | −3,300—−156% | −1,871−191%−89.8% | 2,045+8017%44.2% | 25−94.7%1.3% | 479−40.6%18.0% | 806−56.9%31.8% | 1,871+360%56.0% | 406+49.5%25.9% | 272—19.6% | |
| Interest and finance income | 23+43.5%1.5% | 16r561−95.1%0.8% | 327—15.7% | — | 21+13.7%1.1% | 18+55.6%0.7% | 12+303%0.5% | 2.9+480%0.1% | 0.5—0.0% | — | |
| Interest expense and finance costs | 24+3.4%1.6% | 23+56.4%1.1% | 15+645%0.7% | 2.0−9.1%0.0% | 2.2−68.1%0.1% | 6.9−36.1%0.3% | 11−12.2%0.4% | 12−52.0%0.4% | 26+92.5%1.6% | 13—1.0% | |
| Other non-operating income (expense) | 447−28.1%29.9% | 621+99.2%29.3% | 312+402%15.0% | 62+236%1.3% | 19+63.7%0.9% | 11+1156%0.4% | 0.9—0.0% | −9.4—−0.3% | −25—−1.6% | −13—−1.0% | |
| Income before tax | −155—−10.4% | −2,679—−126% | −1,559−174%−74.8% | 2,108+4723%45.5% | 44−91.1%2.2% | 490−39.3%18.4% | 807−56.6%31.8% | 1,861+388%55.7% | 381—24.3% | — | |
| Income tax | 0—0.0% | 0—0.0% | −123−142%−5.9% | 295—6.4% | −5.7—−0.3% | −18−135%−0.7% | 52−74.6%2.1% | 206—6.2% | — | — | |
| Net income including minority interests | — | −2,679—−126% | −1,436−179%−68.9% | 1,813+3570%39.2% | 49—2.5% | — | — | — | — | — | |
| Net income attributable to shareholders | −155—−10.4% | −2,679—−126% | −1,436−179%−68.9% | 1,813+3570%39.2% | 49−90.3%2.5% | 508−32.7%19.1% | 755−54.4%29.8% | 1,655+334%49.5% | 381+47.5%24.3% | 259—18.7% | |
| Earnings per share, basic | -0.01—— | -0.25—— | -0.15−163%— | 0.24+2300%— | 0.01r0.000.0%— | 0.010.0%— | 0.01−66.7%— | 0.03+200%— | 0.01—— | 0.00—— | |
| Earnings per share, diluted | -0.01—— | -0.25—— | -0.15−163%— | 0.24+2300%— | 0.01r0.000.0%— | 0.010.0%— | 0.01−66.7%— | 0.03+200%— | 0.01—— | 0.00—— | |
| Shares, weighted average (basic) | 11+2.5%— | 11+8.9%— | 9.7+27.5%— | 7.6+12.5%— | 6.7r67−89.5%— | 64+7.8%— | 59+1.4%— | 59+0.0%— | 59+0.0%— | 59—— | |
| Shares, weighted average (diluted) | 11+2.5%— | 11+8.9%— | 9.7+27.5%— | 7.6+12.5%— | 6.7r67−89.5%— | 64+7.2%— | 60+1.5%— | 59+0.1%— | 59+0.5%— | 59—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 11,554+6.6%82.3% | 10,840+378%77.9% | 2,269+147%16.2% | 917r5,338−50.3%9.5% | 1,847+35.5%48.7% | 1,363+98.1%35.2% | 688+71.7%19.5% | 401+11.2%15.9% | 360+81.0%44.4% | 199—35.7% | |
| Short-term investments | 0—0.0% | — | 7,986+82.1%57.0% | 4,385—45.6% | — | — | — | — | — | — | |
| Receivables | 937−24.1%6.7% | 1,235+10.2%8.9% | 1,121+1.6%8.0% | 1,104+13.7%11.5% | 971−24.2%25.6% | 1,281−5.3%33.1% | 1,352+134%38.3% | 579+98.2%23.0% | 292+20.0%36.0% | 243—43.6% | |
| Inventory | 457+30.7%3.3% | 350−22.0%2.5% | 448−7.9%3.2% | 486+15.1%5.1% | 423+30.1%11.2% | 325+154%8.4% | 128−4.2%3.6% | 134+20.7%5.3% | 111+56.0%13.6% | 71—12.7% | |
| Other current assets | 144−7.5%1.0% | 156+27.8%1.1% | 122+17.9%0.9% | 103−35.4%1.1% | 160+63.6%4.2% | 98−27.6%2.5% | 135+210%3.8% | 44+23.5%1.7% | 35+19.3%4.3% | 30—5.3% | |
| Current assets | 13,091+4.1%93.3% | 12,580+3.9%90.4% | 12,105+72.2%86.5% | 7,031+107%73.1% | 3,400+10.9%89.7% | 3,066+33.1%79.2% | 2,303+99.1%65.2% | 1,157+44.9%46.0% | 798+47.0%98.3% | 543—97.3% | |
| Property, plant and equipment | 10−40.1%0.1% | 17−54.2%0.1% | 37−33.6%0.3% | 55−37.7%0.6% | 88+1.3%2.3% | 87+24.4%2.3% | 70+835%2.0% | 7.5−46.8%0.3% | 14−6.0%1.7% | 15—2.7% | |
| Right-of-use (leased) assets | 161+398%1.1% | 32+84.1%0.2% | 18−74.2%0.1% | 68−41.0%0.7% | 116−27.8%3.1% | 160−20.6%4.1% | 202—5.7% | — | — | — | |
| Goodwill | 0—0.0% | — | — | — | — | — | — | — | — | — | |
| Other intangible assets | 0—0.0% | — | — | — | — | — | — | — | — | — | |
| Non-current assets | — | — | — | — | — | — | — | 1,352—53.7% | — | — | |
| Total assets | 14,038+0.8%100% | 13,921−0.5%100% | 13,998+45.5%100% | 9,617+154%100% | 3,789−2.2%100% | 3,873+9.7%100% | 3,532+40.4%100% | 2,517+210%100% | 813+45.6%100% | 558—100% | |
| Accounts payable | 31+46.4%0.2% | 21−24.0%0.2% | 28−71.9%0.2% | 98+2541%1.0% | 3.7−35.1%0.1% | 5.7−87.1%0.1% | 44+168%1.3% | 17+237%0.7% | 4.9−85.2%0.6% | 33—5.9% | |
| Current liabilities | 291+52.1%2.1% | 191−87.1%1.4% | 1,487+144%10.6% | 609+201%6.3% | 203−23.5%5.3% | 265−43.3%6.8% | 468+35.1%13.2% | 346−42.0%13.8% | 597−19.0%73.5% | 738—132% | |
| Lease liabilities (non-current) | 89—0.6% | 0—0.0% | 0−100%0.0% | 18−74.2%0.2% | 68−41.0%1.8% | 116−27.8%3.0% | 160—4.5% | — | — | — | |
| Non-current liabilities | 143r434−49.2%1.0% | 282r282+119%2.0% | 129−32.2%0.9% | 190+133%2.0% | 81−47.5%2.1% | 155−43.6%4.0% | 275+35.0%7.8% | 204—8.1% | — | — | |
| Total liabilities | 434+54.0%3.1% | 282−82.6%2.0% | 1,615—11.5% | — | — | — | — | — | — | — | |
| Retained earnings | −12,203—−86.9% | −12,049—−86.5% | −9,370—−66.9% | −7,934—−82.5% | −9,747—−257% | −9,796—−253% | −10,305—−292% | −11,060—−439% | −12,811—−1577% | −13,192—−2364% | |
| Shareholders' equity | 13,604−0.3%96.9% | 13,640+10.2%98.0% | 12,383+40.4%88.5% | 8,818+152%91.7% | 3,505+1.5%92.5% | 3,453+23.8%89.2% | 2,790+41.8%79.0% | 1,967+814%78.1% | 215—26.5% | −180—−32.2% | |
| Total liabilities and equity | 14,038+0.8%100% | 13,921−0.5%100% | 13,998+45.5%100% | 9,617+154%100% | 3,789−2.2%100% | 3,873+9.7%100% | 3,532+40.4%100% | 2,517+210%100% | 813+45.6%100% | 558—100% | |
| Shares outstanding | 11+0.4%— | 11r11+2.8%— | 11r11+13.5%— | 9.3r9.3+37.0%— | 6.8r67−90.0%— | 67+10.3%— | 61+4.1%— | 590.0%— | 59+0.0%— | 59—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 6.7−77.4%0.4% | 30−36.8%1.4% | 47+37.8%2.3% | 34+11.8%0.7% | 31+41.9%1.6% | 22+99.1%0.8% | 11+52.1%0.4% | 7.1−5.3%0.2% | 7.5+2.7%0.5% | 7.3—0.5% | |
| Share-based compensation | 126−95.4%8.4% | 2,733+107%129% | 1,321r1,347—63.4% | 0—0.0% | 0—0.0% | 0—0.0% | — | — | — | — | |
| Cash from operating activities | 714+20.0%47.8% | 595—28.1% | −19—−0.9% | −43r−8.1−108%−0.9% | 513−27.0%26.3% | 702+94.8%26.4% | 361+782%14.2% | 41−77.0%1.2% | 178−12.4%11.3% | 203—14.6% | |
| Capital expenditure | 0—0.0% | −9.9—−0.5% | −29—−1.4% | −0.8—−0.0% | −32—−1.6% | −39—−1.5% | −73—−2.9% | −0.5—−0.0% | −6.6—−0.4% | −1.4—−0.1% | |
| Cash from investing activities | 0−100%0.0% | 7,976—377% | −3,629—−174% | −4,386r−0.8—−94.8% | −32—−1.6% | −39—−1.5% | −73—−2.9% | −0.5—−0.0% | −6.6—−0.4% | −1.4—−0.1% | |
| Shares issued | — | — | 5,000+42.9%240% | 3,500—75.6% | — | — | — | — | 0.4—0.0% | — | |
| Cash from financing activities | — | — | 5,000+42.9%240% | 3,500+124900%75.6% | 2.8−74.5%0.1% | 11—0.4% | — | — | −9.6—−0.6% | −14—−1.0% | |
| Change in cash | — | — | — | — | — | 675+135%25.4% | 287+611%11.3% | 40−75.0%1.2% | 161−14.1%10.3% | 188—13.6% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 4,949+172%100% | 3,329+763%100% | 961+167%100% | 390−18.6%100% | 269*−54.6%100% | 386−42.3%100% | 360−21.6%100% | 479+20.3%100% | 592*+86.5%100% | 668—100% | 459—100% | 398—100% | 318*—100% | |
| Cost of revenue | 2,027+138%41.0% | 1,126+441%33.8% | 604+258%62.8% | 199−3.0%51.1% | 98*−63.3%36.5% | 208−27.7%54.0% | 169−26.3%46.8% | 205−11.8%42.9% | 268*+64.9%45.3% | 288—43.1% | 229—49.8% | 233—58.4% | 163*—51.2% | |
| Gross profit | 2,921+202%59.0% | 2,203+1141%66.2% | 357+86.6%37.2% | 191−30.4%48.9% | 171*−47.3%63.5% | 178−53.3%46.0% | 192−16.8%53.2% | 274+65.3%57.1% | 324*+109%54.7% | 380—56.9% | 230—50.2% | 166—41.6% | 155*—48.8% | |
| Research and development | 210+14.7%4.2% | 58+32.2%1.7% | 48+11.8%5.0% | 56+24.0%14.3% | 48*−5.9%17.9% | 440.0%11.3% | 43+2.6%12.0% | 45+8.7%9.4% | 51*+17.5%8.6% | 44—6.5% | 42—9.2% | 41—10.4% | 44*—13.7% | |
| Selling and marketing | 429+40.5%8.7% | 203+184%6.1% | 89+55.5%9.3% | 75−18.1%19.1% | 63*−26.7%23.4% | 71−22.2%18.5% | 57−24.5%15.9% | 91+31.9%19.0% | 86*+64.6%14.5% | 92—13.7% | 76—16.5% | 69—17.3% | 52*—16.4% | |
| General and administrative | 1,551+46.2%31.3% | 345+402%10.4% | 237+262%24.6% | 222−0.8%56.9% | 747r260*+6.3%278% | 69r205−90.6%17.8% | 65r264−94.8%18.1% | 224−81.6%46.7% | 703*−45.1%119% | 727—109% | 1,255—273% | 1,215—305% | 1,280*—403% | |
| Operating expenses | 2,630+39.6%53.1% | 982+207%29.5% | 925+154%96.3% | 352−2.1%90.4% | 371*−55.8%138% | 320−62.9%83.0% | 364−73.5%101% | 360−72.9%75.1% | 840*−38.9%142% | 863—129% | 1,373—299% | 1,325—333% | 1,376*—433% | |
| Operating income | 291—5.9% | 1,221—36.7% | −568—−59.1% | −162—−41.4% | −200*—−74.5% | −143—−37.0% | −173—−47.9% | −86—−17.9% | −516*—−87.1% | −482—−72.2% | −1,142—−249% | −1,160—−291% | −1,221*—−384% | |
| Interest and finance income | 30+41.3%0.6% | 8.5+41.7%0.3% | 7.8+41.8%0.8% | 7.2+46.9%1.8% | 6.6*+34.7%2.5% | 6.0+39.5%1.6% | 5.5+48.6%1.5% | 4.9+53.1%1.0% | 4.9r550*−98.4%0.8% | 4.3—0.6% | 3.7—0.8% | 3.2—0.8% | 311*—97.9% | |
| Interest expense and finance costs | 24−0.4%0.5% | 5.8−5.0%0.2% | 6.2+1.6%0.6% | 6.0+1.7%1.5% | 6.0*0.0%2.2% | 6.1+5.2%1.6% | 6.1+5.2%1.7% | 5.9+3.5%1.2% | 6.0*+1.7%1.0% | 5.8—0.9% | 5.8—1.3% | 5.7—1.4% | 5.9*—1.9% | |
| Other non-operating income (expense) | 501+8.3%10.1% | 201+73.4%6.0% | 96−15.9%10.0% | 99−10.9%25.5% | 105*−13.5%39.2% | 116−49.9%30.0% | 114−16.9%31.6% | 111−15.3%23.2% | 122*−5.4%20.6% | 231—34.6% | 137—29.8% | 131—33.0% | 129*—40.5% | |
| Income before tax | 793—16.0% | 1,422—42.7% | −472—−49.1% | −62−344%−16.0% | −95*—−35.3% | −27—−6.9% | −59—−16.3% | 26—5.3% | −394*—−66.6% | −251—−37.6% | −1,005—−219% | −1,028—−258% | −1,092*—−344% | |
| Income tax | 25—0.5% | 25—0.8% | 0—0.0% | 0—0.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0*—0.0% | |
| Net income including minority interests | — | — | — | — | — | — | — | — | −394*—−66.6% | −251—−37.6% | −1,005—−219% | −1,028—−258% | −1,092*—−344% | |
| Net income attributable to shareholders | 768—15.5% | 1,397—42.0% | −472—−49.1% | −62−344%−16.0% | −95*—−35.3% | −27—−6.9% | −59—−16.3% | 26—5.3% | −394*—−66.6% | −251—−37.6% | −1,005—−219% | −1,028—−258% | −1,092*—−344% | |
| Earnings per share, basic | — | 0.12—— | -0.04—— | -0.01−400%— | — | 0.00—— | -0.01—— | 0.00—— | — | -0.02—— | -0.10—— | -0.10—— | — | |
| Earnings per share, diluted | — | 0.12—— | -0.04—— | -0.01−400%— | — | 0.00—— | -0.01—— | 0.00—— | — | -0.02—— | -0.10—— | -0.10—— | — | |
| Shares, weighted average (basic) | 12+6.7%— | 12+6.7%— | 11+5.6%— | 11+2.5%— | — | 11+2.8%— | 11+2.8%— | 11+2.8%— | — | 11—— | 11—— | 11—— | — | |
| Shares, weighted average (diluted) | 12+6.7%— | 12+6.7%— | 11+5.6%— | 11+2.5%— | — | 11+2.8%— | 11+2.8%— | 11+2.8%— | — | 11—— | 11—— | 11—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 7,292—41.5% | 7,292−36.6%41.5% | 10,687−5.4%66.8% | 11,913+6.3%83.1% | 11,554+6.6%82.3% | 11,498+5.1%81.5% | 11,295+141%79.5% | 11,209+211%79.9% | 10,840+378%77.9% | 10,941—77.2% | 4,678—33.6% | 3,600—25.9% | 2,269—16.2% | |
| Short-term investments | 385—2.2% | 385—2.2% | — | — | 0—0.0% | — | — | — | — | — | 5,823—41.8% | 6,911—49.7% | 7,986—57.0% | |
| Receivables | 1,807—10.3% | 1,807+83.1%10.3% | 1,268+11.8%7.9% | 1,132−4.0%7.9% | 937−24.1%6.7% | 987−21.3%7.0% | 1,134+3.2%8.0% | 1,179+20.2%8.4% | 1,235+10.2%8.9% | 1,254—8.8% | 1,098—7.9% | 982—7.1% | 1,121—8.0% | |
| Inventory | 1,872—10.7% | 1,872+363%10.7% | 1,712+360%10.7% | 404+24.8%2.8% | 457+30.7%3.3% | 404+15.0%2.9% | 372+16.6%2.6% | 324−12.6%2.3% | 350−22.0%2.5% | 352—2.5% | 319—2.3% | 370—2.7% | 448—3.2% | |
| Other current assets | 204—1.2% | 204+108%1.2% | 168+47.7%1.1% | 87−7.8%0.6% | 144−7.5%1.0% | 98−24.1%0.7% | 114+8.6%0.8% | 94−6.5%0.7% | 156+27.8%1.1% | 130—0.9% | 105—0.8% | 101—0.7% | 122—0.9% | |
| Current assets | 12,246—69.7% | 12,246−5.7%69.7% | 13,835+7.1%86.4% | 13,536+5.7%94.4% | 13,091+4.1%93.3% | 12,987+2.5%92.1% | 12,915+5.2%90.9% | 12,807+5.2%91.3% | 12,580+3.9%90.4% | 12,676—89.4% | 12,276—88.1% | 12,169—87.5% | 12,105—86.5% | |
| Property, plant and equipment | 304—1.7% | 304+2497%1.7% | 316+2278%2.0% | 21+41.3%0.1% | 10−40.1%0.1% | 12−43.5%0.1% | 13−43.4%0.1% | 15−50.5%0.1% | 17−54.2%0.1% | 21—0.1% | 24—0.2% | 30—0.2% | 37—0.3% | |
| Right-of-use (leased) assets | 508—2.9% | 508+182%2.9% | 569+187%3.6% | 142+986%1.0% | 161+398%1.1% | 180+247%1.3% | 198+181%1.4% | 13+198%0.1% | 32+84.1%0.2% | 52—0.4% | 71—0.5% | 4.4—0.0% | 18—0.1% | |
| Goodwill | 490—2.8% | 490—2.8% | 490—3.1% | — | 0—0.0% | — | — | — | — | — | — | — | — | |
| Other intangible assets | 283—1.6% | 283—1.6% | 290—1.8% | — | 0—0.0% | — | — | — | — | — | — | — | — | |
| Total assets | 17,565—100% | 17,565+24.5%100% | 16,006+12.7%100% | 14,339+2.2%100% | 14,038+0.8%100% | 14,103−0.5%100% | 14,200+1.9%100% | 14,032+0.9%100% | 13,921−0.5%100% | 14,177—100% | 13,934—100% | 13,905—100% | 13,998—100% | |
| Accounts payable | 460—2.6% | 460+613%2.6% | 430+300%2.7% | 34−46.7%0.2% | 31+46.4%0.2% | 65−5.6%0.5% | 108+7.4%0.8% | 63+31.9%0.4% | 21−24.0%0.2% | 68—0.5% | 100—0.7% | 48—0.3% | 28—0.2% | |
| Current liabilities | 980—5.6% | 980+284%5.6% | 1,147+162%7.2% | 278−0.8%1.9% | 291+52.1%2.1% | 255−93.4%1.8% | 438−87.4%3.1% | 281−88.5%2.0% | 191−87.1%1.4% | 3,891—27.4% | 3,476—24.9% | 2,431—17.5% | 1,487—10.6% | |
| Lease liabilities (non-current) | 260—1.5% | 260+138%1.5% | 328+331%2.1% | 67—0.5% | 89—0.6% | 109—0.8% | 76—0.5% | — | 0—0.0% | — | — | — | 0—0.0% | |
| Non-current liabilities | 436—2.5% | 436+151%2.5% | 413−29.9%2.6% | 390+7.1%2.7% | 143r434−49.2%1.0% | 174+74.1%1.2% | 589+439%4.2% | 364+206%2.6% | 282r282+119%2.0% | 100—0.7% | 109—0.8% | 119—0.9% | 129—0.9% | |
| Total liabilities | 1,416—8.1% | 1,416—8.1% | 1,560—9.7% | — | 434+54.0%3.1% | — | — | — | 282−82.6%2.0% | — | — | — | 1,615—11.5% | |
| Retained earnings | −11,341—−64.6% | −11,341—−64.6% | −12,738—−79.6% | −12,266—−85.5% | −12,203—−86.9% | −12,108—−85.9% | −12,082—−85.1% | −12,023—−85.7% | −12,049—−86.5% | −11,654—−82.2% | −11,403—−81.8% | −10,398—−74.8% | −9,370—−66.9% | |
| Shareholders' equity | 16,149—91.9% | 16,149+18.1%91.9% | 14,446+6.1%90.3% | 13,949+2.1%97.3% | 13,604−0.3%96.9% | 13,674+34.2%97.0% | 13,611+31.5%95.8% | 13,667+20.4%97.4% | 13,640+10.2%98.0% | 10,186—71.8% | 10,349—74.3% | 11,354—81.7% | 12,383—88.5% | |
| Total liabilities and equity | 17,565—100% | 17,565+24.5%100% | 16,006+12.7%100% | 14,339+2.2%100% | 14,038+0.8%100% | 14,103−0.5%100% | 14,200+1.9%100% | 14,032+0.9%100% | 13,921−0.5%100% | 14,177—100% | 13,934—100% | 13,905—100% | 13,998—100% | |
| Shares outstanding | 12—— | 12+10.1%— | 12+8.8%— | 11+2.9%— | 11+0.4%— | 11+2.8%— | 11+2.8%— | 11+2.8%— | 11r11+2.8%— | 11—— | 11—— | 11—— | 11r11—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | — | — | — | 2.4+41.2%0.6% | 1.7*−57.5%0.6% | 1.6*−60.0%0.4% | 1.7*−77.3%0.5% | 1.7−88.0%0.4% | 4.0*−72.4%0.7% | 4.0*—0.6% | 7.5*—1.6% | 14—3.6% | 15*—4.6% | |
| Share-based compensation | — | — | 41*+1833%4.2% | 29+22.4%7.4% | 54r120*−98.0%20.1% | 2.1—0.5% | 2.1—0.6% | 24r2.1—4.9% | 2,733r407*+204%461% | 0r501—0.0% | 0r890—0.0% | 0r890—0.0% | 900*—283% | |
| Cash from operating activities | −310−156%−6.3% | −663*−427%−19.9% | 324*+279%33.7% | −27−107%−6.9% | 56*—20.8% | 203*−54.1%52.5% | 86*—23.8% | 370+39.9%77.2% | −101*—−17.1% | 441*—66.0% | −9.5*—−2.1% | 264—66.3% | −187*—−58.7% | |
| Capital expenditure | −19—−0.4% | −5.8*—−0.2% | 0*—0.0% | −14—−3.5% | 0*—0.0% | 0*—0.0% | 0*—0.0% | 0—0.0% | 0*—0.0% | −1.2*—−0.2% | −0.7*—−0.2% | −8.0—−2.0% | 0*—0.0% | |
| Cash from investing activities | −4,696—−94.9% | −2,932*—−88.1% | −1,750*—−182% | −14—−3.5% | 0*—0.0% | 0*−100%0.0% | 0*−100%0.0% | 0−100%0.0% | 0*—0.0% | 5,822*—871% | 1,087*—237% | 1,067—268% | −3,600*—−1134% | |
| Shares issued | — | 200*—6.0% | 200*—20.8% | 400—103% | — | 0*—0.0% | 0*—0.0% | 0—0.0% | — | — | — | — | 0*—0.0% | |
| Cash from financing activities | — | 200*—6.0% | 200*—20.8% | 400—103% | — | 0*—0.0% | 0*—0.0% | 0—0.0% | — | — | — | — | 0*—0.0% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Nocopi Technologies Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Productand Other Sales$1 M59%-45%
- Licenses Royalties And Fees$1 M41%+20%
Countries and regions
- Asia$1 M55%-47%
- North America$1 M40%+23%
- 🇦🇺 Australia$0 M5.4%-11%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where Nocopi Technologies Inc. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office | — |
| 🇦🇺 Australia | $0 M5.4% |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Nocopi Technologies Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Michael S. Liebowitz and Matthew C. Winger | $118 K | $118 K | $354 K | — |
| 2024Michael S. Liebowitz | $150 K | $150 K | $385 K | — |
| 2023Michael A Feinstein, M.D. and Michael S. Liebowitz | $224 K | $224 K | $379 K | — |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Nocopi Technologies Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
- Auditor changedFiling
Auditor changed 1 · Acquisition or sale completed 1 · Directors and officers 10 · Material agreement 3 · Agreement ended 2 · Unregistered share sale 3 · Shareholder vote 4 · Results announced 1
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Acquisition or sale completedMaterial agreementUnregistered share sale | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Auditor changed | 8-K | |
| Shareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersAgreement ended | 8-K | |
| Agreement endedShareholder vote | 8-K | |
| Directors and officers | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2022 | $4 M | Private placement after listing | $2 to $10 million | 2 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How Nocopi Technologies Inc. compares in Chemicals
- Revenue$1 M · higher than 2% of 421
- Net margin-10.1% · higher than 6% of 409
- Revenue growth-29.7% · higher than 11% of 111
Peer comparison · Chemicals
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Nocopi Technologies Inc.🇺🇸 | $28 M | — | -10.1% | -29.7% |
| Linde plc🇬🇧 | $231.0 B | 33.0× | 19.3% | +3.0% |
| Air Liquide🇫🇷 | $124.8 B | 29.9× | 13.1% | +3.8% |
| The Sherwin-Williams Company🇺🇸 | $81.4 B | 30.4× | 10.7% | +2.1% |
| Ecolab Inc.🇺🇸 | $79.7 B | 38.3× | 12.0% | +2.2% |
| Shin-Etsu Chemical Co., Ltd.🇯🇵 | $74.3 B | 23.1× | 18.4% | — |
| Air Products and Chemicals, Inc.🇺🇸 | $66.5 B | — | -0.4% | -0.5% |
| Nan Ya Plastics Corporation🇹🇼 | $55.1 B | 372.9× | 1.7% | — |
| BASF SE🇩🇪 | $52.7 B | 27.4× | 2.7% | -18.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Linde plc$231.0 B
- Air Liquide$124.8 B
- The Sherwin-Williams Company$81.4 B
- Ecolab Inc.$79.7 B
- Shin-Etsu Chemical Co., Ltd.$74.3 B
- Air Products and Chemicals, Inc.$66.5 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 4, 2026
Figures from SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Nocopi Technologies Inc.? Verify and update this profile — free
Show Nocopi Technologies Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.